Stay updated on ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Sign up to get notified when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.

Latest updates to the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference3%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.3%
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check22 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference5%
- Check29 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference1.0%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
Stay in the know with updates to ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the ALADDIN Clinical Trial: dAroLutamide in Prostate Cancer page.